1 | Patients | 2.34% | |
2 | Cancer | 1.56% | |
3 | Sugar | 1.56% | |
4 | Results | 1.56% | |
5 | Blood | 1.56% | |
6 | ASCO | 1.56% | |
7 | Phase | 1.56% | |
8 | Urothelial | 0.78% | |
9 | Immune | 0.78% | |
10 | Failure | 0.78% | |
11 | Clinical | 0.78% | |
12 | Portfolio | 0.78% | |
13 | Nivolumab | 0.78% | |
14 | Signs | 0.78% | |
15 | pCR | 0.78% | |
16 | Clinically | 0.78% | |
17 | Risk | 0.78% | |
18 | CDC | 0.78% | |
19 | Adenotonsillectomy | 0.78% | |
20 | Neoadjuvant | 0.78% | |
21 | Study | 0.78% | |
22 | Rapid | 0.78% | |
23 | Reviewed | 0.78% | |
24 | Ejection | 0.78% | |
25 | PET | 0.78% | |
26 | Natural | 0.78% | |
27 | Fraction | 0.78% | |
28 | Advanced | 0.78% | |
29 | Prevalence | 0.78% | |
30 | Systematic | 0.78% | |
31 | New | 0.78% | |
32 | Molecular | 0.78% | |
33 | Effusion-Synovitis | 0.78% | |
34 | Osteoarthritis | 0.78% | |
35 | ctDNA? | 0.78% | |
36 | Czechia | 0.78% | |
37 | Have | 0.78% | |
38 | Questions | 0.78% | |
39 | Perioperative | 0.78% | |
40 | Cisplatin-Ineligible | 0.78% | |
41 | (BT8009) | 0.78% | |
42 | Rises | 0.78% | |
43 | Review | 0.78% | |
44 | Surgeries | 0.78% | |
45 | Sustains | 0.78% | |
46 | Tympanostomy | 0.78% | |
47 | Advantage | 0.78% | |
48 | School | 0.78% | |
49 | Nectin-4?targeting | 0.78% | |
50 | Pevedotin | 0.78% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|